DIGITAL EDITION

ARCHIVES

Category: Past Articles

The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics

by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA, BCGP, BCPP; EILEEN TRIGOBOFF, RN, PMHCNS-BC, DNS, DABFN; and CLAUDIA LEE, MD Dr. O’Donnell is with Edward Hines Jr. Veterans

Risk Management: EHR Use and Emerging Risks

by Justin A. Pope, JD Mr. Pope is a Senior Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:

Artificial Intelligence and Neurorehabilitation: Fact vs. Fiction

by Nicola Fiorente, MD; Sepehr Mojdehdehbaher, BSc; and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio and Sport in Cittadella (PD), Italy. Dr. Mojdehdehbaher is with Engineering

Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials

by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown

Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward

by William P. Horan, PhD; Gary Sachs, MD; Dawn I. Velligan, PhD; Michael Davis, MD, PhD; Richard S.E. Keefe, PhD; Ni A. Khin, MD; Florence Butlen-Ducuing, MD, PhD; and Philip

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group

by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf, MD; Joan Fallon, BS, DC; Larry D. Alphs, MD, PhD; Maria T. Acosta, MD; Anna-Karin Berger, PhD; Simon Day, PhD;

ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain

by Edson Silva-Filho, PhD, and Rodrigo Pegado, PhD Both authors are with Graduate Program in Heath Science, Graduate Program in Physical Therapy, Federal University of Rio Grande do Norte in

Risk Management: Blurring the Lines—Boundary Violation

by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures:

Music in Parkinson’s Disease Rehabilitation: Are We Heading in the Right Direction?

by Nicola Fiorente, MD, and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio & Sport in Cittadella (PD), Italy. Dr. Calabrò is with IRCCS Centro Neurolesi “Bonino-Pulejo”

Medical Student-patients: Mental Wellness During the Pandemic

by Kari Harper, MD; Nita Bhatt, MD, MPH; and Julie P. Gentile, MD, MBA Dr. Harper is Assistant Professor, Department of Psychiatry at Wright State University in Dayton, Ohio. Dr.

The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials

by Waguih William IsHak, MD, FAPA; Paloma Garcia, BS Candidate; Rachel Pearl, MD; Jonathan Dang, MD; Catherine William, BS; Jayant Totlani, BS, DO candidate; and Itai Danovitch, MD, MBA Drs.

Seizure and Other Catastrophes due to Bupropion Overdose: Recent Case Report and Review of Published Cases

by Isha Snehal, MD; Garret Lorenzen, MS; and Ashish Sharma, MD Dr. Snehal is with Department of Neurological Sciences, University of Nebraska Medical Center in Omaha, Nebraska. Mr. Lorenzen is

Risk Management: Treating Patients at Risk for Suicide: Part 1

by Donna Vanderpool, MBA, JD Ms. Vanderpool is Director of Risk Management at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: